Credo Life Science
Posted on 27th January 2022

Posted on 27th January 2022

Esomeprazole, the S-enantiomer of omeprazole, is one of the most prescribed proton pump inhibitors globally. As demand grows across regulated and semi-regulated markets, pharmaceutical companies face the challenge of sourcing from an Esomeprazole Manufacturer that guarantees consistent quality, regulatory compliance, and reliable supply.
Esomeprazole is available in multiple formulations — delayed-release capsules, tablets, and injectables. Its stereoselective synthesis requires a manufacturer with advanced chiral chemistry capabilities and strict process controls. The global PPI market is expected to surpass USD 5 billion in the coming years, reflecting the massive demand for quality Esomeprazole.
Esomeprazole pellets require a sub-coating to protect the drug from moisture, followed by an enteric coat to prevent premature release in the stomach. This multi-layer process demands precise coating weight gain control, film integrity testing, and dissolution profiling at multiple pH levels. Manufacturers without dedicated pellet manufacturing lines often struggle to meet these demands.
At Credo Life Sciences, we manufacture Esomeprazole Magnesium Trihydrate and Esomeprazole Pellets using validated processes in our GMP-certified facility. Our fluid bed coaters, in-line spray systems, and pH-specific dissolution testing equipment ensure every batch meets specifications. We provide comprehensive analytical reports, regulatory documentation, and stability data for global submissions.
Selecting the best Esomeprazole Manufacturer requires thorough due diligence. With Credo Life Sciences, you partner with an organisation that combines scientific expertise, manufacturing excellence, and dedicated customer support.